Literature DB >> 15018871

Electrical storm in Brugada syndrome successfully treated using isoprenaline.

P Maury1, P Couderc, M Delay, S Boveda, J Brugada.   

Abstract

A case of an electrical storm occurring in a patient implanted with a cardioverter-defibrillator for Brugada syndrome is reported. Recurrent ventricular fibrillation was initiated by short-coupled isolated monomorphic ventricular premature beats probably originating from the right ventricular outflow tract, associated with a manifest electrocardiographic pattern of Brugada syndrome. Infusion of atropine accelerated the heart rate but did not prevent ventricular fibrillation, however, low doses of isoprenaline quickly obviated any recurrence of ventricular fibrillation. This was associated with the disappearance of the short-coupled premature beats together with a normalization of the electrocardiographic pattern. Possible mechanisms are discussed according to the accepted pathophysiological hypothesis.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15018871     DOI: 10.1016/j.eupc.2003.11.009

Source DB:  PubMed          Journal:  Europace        ISSN: 1099-5129            Impact factor:   5.214


  24 in total

Review 1.  The Diagnosis, Risk Stratification, and Treatment of Brugada Syndrome.

Authors:  Johannes Steinfurt; Jürgen Biermann; Christoph Bode; Katja E Odening
Journal:  Dtsch Arztebl Int       Date:  2015-06-05       Impact factor: 5.594

2.  Successful acute and long-term management of electrical storm in Brugada syndrome using orciprenaline and quinine/quinidine.

Authors:  Patrick A Schweizer; Rüdiger Becker; Hugo A Katus; Dierk Thomas
Journal:  Clin Res Cardiol       Date:  2010-03-11       Impact factor: 5.460

Review 3.  J-Wave syndromes expert consensus conference report: Emerging concepts and gaps in knowledge.

Authors:  Charles Antzelevitch; Gan-Xin Yan; Michael J Ackerman; Martin Borggrefe; Domenico Corrado; Jihong Guo; Ihor Gussak; Can Hasdemir; Minoru Horie; Heikki Huikuri; Changsheng Ma; Hiroshi Morita; Gi-Byoung Nam; Frederic Sacher; Wataru Shimizu; Sami Viskin; Arthur A M Wilde
Journal:  Europace       Date:  2017-04-01       Impact factor: 5.214

4.  Intracellular calcium dynamics, shortened action potential duration, and late-phase 3 early afterdepolarization in Langendorff-perfused rabbit ventricles.

Authors:  Liang Tang; Boyoung Joung; Masahiro Ogawa; Peng-Sheng Chen; Shien-Fong Lin
Journal:  J Cardiovasc Electrophysiol       Date:  2012-07-18

Review 5.  J-Wave syndromes expert consensus conference report: Emerging concepts and gaps in knowledge.

Authors:  Charles Antzelevitch; Gan-Xin Yan; Michael J Ackerman; Martin Borggrefe; Domenico Corrado; Jihong Guo; Ihor Gussak; Can Hasdemir; Minoru Horie; Heikki Huikuri; Changsheng Ma; Hiroshi Morita; Gi-Byoung Nam; Frederic Sacher; Wataru Shimizu; Sami Viskin; Arthur A M Wilde
Journal:  Heart Rhythm       Date:  2016-07-13       Impact factor: 6.343

6.  A mutation causing Brugada syndrome identifies a mechanism for altered autonomic and oxidant regulation of cardiac sodium currents.

Authors:  Takeshi Aiba; Federica Farinelli; Geran Kostecki; Geoffrey G Hesketh; David Edwards; Subrata Biswas; Leslie Tung; Gordon F Tomaselli
Journal:  Circ Cardiovasc Genet       Date:  2014-05-02

7.  Isoprenaline and quinidine to calm Brugada VF storm.

Authors:  Guy Furniss
Journal:  BMJ Case Rep       Date:  2012-08-13

Review 8.  J-wave syndromes: Brugada and early repolarization syndromes.

Authors:  Charles Antzelevitch; Gan-Xin Yan
Journal:  Heart Rhythm       Date:  2015-04-11       Impact factor: 6.343

9.  Brugada syndrome: Controversies in Risk stratification and Management.

Authors:  Lm Nunn; J Bhar-Amato; Pd Lambiase
Journal:  Indian Pacing Electrophysiol J       Date:  2010-09-05

10.  Electrical storm reversible by isoproterenol infusion in a striking case of early repolarization.

Authors:  Anne Bernard; Olivier Genée; Caroline Grimard; Frédéric Sacher; Laurent Fauchier; Dominique Babuty
Journal:  J Interv Card Electrophysiol       Date:  2009-01-19       Impact factor: 1.900

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.